SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidias board investigation into CEO Jensen Huangs relationship with a businesswoman alleged to have ties to Chinese intelligence has raised governance, disclosure and leadership concerns. Traders are divided between treating the controversy as a temporary distraction and buying on the strength of Nvidias AI business, and worrying that further scrutiny could threaten Huangs position.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is drawing attention after a sharp, high-volume selloff ahead of its quarterly results; traders speculate that results leaked, but the claim is unconfirmed. The debate centers on whether growth and guidance can offset potential margin pressure as the company expands access to Eli Lillys branded obesity drugs, with bullish dip-buyers facing bearish earnings concerns.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

TTDs sharp rally and unusually active options trading ahead of its Q3 report are drawing attention, with traders speculating about short covering or an earnings leakneither is confirmed. Bulls see potential for a rebound if results and forward guidance improve, while bears warn that the run-up could fade given concerns about slowing ad growth and the risk of another disappointing outlook.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics BRIUMVI-driven quarterly revenue beat and raised full-year outlook are the main focus. Traders debated the initial post-earnings drop and recovery, while many are watching Phase 3 results for a subcutaneous BRIUMVI formulation; short-squeeze and buyout talk remains speculative.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors HOPE-3 cardiac results for deramiocel received an American Heart Association research award, renewing attention ahead of the FDAs pending decision on the therapy for Duchenne muscular dystrophy. Traders see the recognition and physician support as strengthening the case for approval, while others note that an award does not determine the FDA outcome and the cardiac evidence faced a negative advisory-panel vote.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X ETF

Sharp swings in semiconductor shares have drawn attention to SOXS, with traders citing worries about an AI and data-center spending slowdown and a broader chip-sector repricing. The community is split between expecting more downside and anticipating a rebound, while warning that volatility and the ETFs daily-reset leverage make it risky to hold.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXOs preliminary third-quarter results and Brad Jacobs upbeat discussion of the business outlook have fueled a sharp rally. Many traders are cheering the update and speculating that short covering could add momentum, while some are cautious about a post-earnings pullback.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels SITC data on CAN-2409s systemic immune activation and transient viral clearance is drawing attention as supportive evidence for the prostate-cancer BLA planned for Q4, following positive Phase 3 results. Bulls see the data and filing as catalysts, while skeptics question the BLA timeline, managements credibility and whether enthusiasm could fade in a sell-the-news reaction.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CTS vs. WEGZY: Which Stock Is the Better Value Option?

Does CTS (CTS) Have the Potential to Rally 27.3% as Wall Street Analysts Expect?

The mean of analysts' price targets for CTS (CTS) points to a 27.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Is CTS (CTS) Stock Outpacing Its Computer and Technology Peers This Year?

Here is how CTS (CTS) and Lattice Semiconductor (LSCC) have performed compared to their sector so far this year.

CTS (CTS) Q3 Earnings and Revenues Top Estimates

CTS (CTS) delivered earnings and revenue surprises of +16.67% and +2.32%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

CTS Corp Reveals Rise In Q3 Bottom Line

(RTTNews) - CTS Corp (CTS) reported a profit for its third quarter that Increases, from the same period last year...

CTS Crosses Below Key Moving Average Level

In trading on Monday, shares of CTS Corp (Symbol: CTS) crossed below their 200 day moving average of $56.48, changing hands as low as $55.95 per share. CTS Corp shares are currently trading off about 1.9% on the day. The chart below shows the one year performance of CTS shares...

TTDKY or CTS: Which Is the Better Value Stock Right Now?

TTDKY vs. CTS: Which Stock Is the Better Value Option?

Are Computer and Technology Stocks Lagging  CTS (CTS) This Year?

Here is how CTS (CTS) and Amtech Systems (ASYS) have performed compared to their sector so far this year.

Should ALNT Stock Be in Your Portfolio After a 143% Surge in a Year?

Allient's 143% one-year surge is backed by record orders, a growing backlog, margin gains and rising 2026 earnings estimates.

Vicor (VICR) Surges 17.7%: Is This an Indication of Further Gains?

Vicor (VICR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

• Reported GAAP EPS of $0.77 up 28.33% YoY
• Reported revenue of $149.58M up 4.62% YoY
• CTS increased 2026 sales guidance from $565M to $580M and adjusted diluted EPS from $2.55 to $2.78, assuming continuation of current market conditions.

CTS disclosed supply chain disruptions, including rare earth element availability and cost risks, and identified key-customer reliance and rapid technological change as factors that may affect future operating results and financial condition.

CTS reported diversified end-market sales growth and 60% of sales from those markets, higher adjusted gross margin and adjusted diluted EPS, and increased operating cash flow year over year.

CTS Corp. engages in the design and manufacture of sensors, connectivity components, and actuators. Its products include controls, pedals, piezo sensing products, sensors, switches, transducers, electromagnetic and radio frequency interference filters, capacitors, frequency control, resistors, piezo microactuators, and rotary microactuators. The company was founded by A. J. Briggs, George A. Briggs, and S. A. Buffington in 1896 and is headquartered in Lisle, IL.

CTS Corp.

Bearish Sentiment

Buying the dip

Selling or trimming

Holding

Waiting for the investigation results to decide

Nvidia ($NVDA) is down about 4% after its board opened an investigation into CEO Jensen Huang. What are you doing with the stock?

Stocktwits

) is down about 4% after its board opened an investigation into CEO Jensen Huang. What are you doing with the stock?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '26	$0.67	--	--	N/A
Q3 '26	$0.65	$0.77	17.86%	BEAT
Q2 '26	$0.61	$0.74	21.31%	BEAT
Q1 '26	$0.52	$0.62	19.23%	BEAT
Q4 '25	$0.60	$0.62	3.33%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

CTS Earnings

Latest Earnings Results: Q3 '26

Historical Earnings